88
77
Growth Score 88 in past quarter
-3 pts
Heat Score 77 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
VenBio is a life sciences investment firm that partners with industry leaders to build medicines and technologies.
Corey Goodman: Founding PartnerPast Role: Exelixis, Co-Founder- Robert Adelman: Co-founder and Emeritus Managing PartnerPast Role: OrbiMed, Partner
About the Company
VenBio invests in promising companies at various stages: from early to late stages, and from academic startups to spinouts. It tends to lead most of its investments, and it enjoys building syndicates and teams.
The company is mindful of potential acquisition partners from the outset, and it ensures that its companies are best positioned to meet
their requirements. This includes IP, CMC, and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Its team’s expertise and involvement help companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that they work with.
